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Abstract
Background Although ceramic-on-ceramic bearings for
total hip arthroplasty (THA) show promising results in
terms of bearing-surface wear, fracture of the bearing,
insertional chips, and squeaking remain a concern.
Questions/purposes Our primary objective of this report
was to determine overall survivorship of a titanium-
encased ceramic-on-ceramic bearing couple. Our
secondary objectives were to evaluate for ceramic fracture,
insertional chips, osteolysis, and device squeaking.
Methods Six surgeons at six institutions implanted 194
patients (209 hips) with an average age of 52 years with
cementless hips and alumina ceramic bearings. One hun-
dred thirty-seven patients (146 hips) have 10-year followup
(70%). We determined Kaplan-Meier survivorship of the
bearing surface and implant system and collected radio-
graphic and clinical data to evaluate for osteolysis and
squeaking.
Results Survivorship using revision for any reason as the
end point was 97% at 10 years and survivorship end point
bearing surface failure or aseptic loosening of 99%. There
was one ceramic insert fracture (0.5%), there were no
insertional chips, there was no visible osteolysis on AP and
lateral radiographs, and there was a 1% patient-
self-reported incidence of squeaking at the last clinical
followup. Six hips underwent revision (3.7%).
Conclusions Ceramic bearings for THA with a titanium-
encased insert have high survivorship at 10 years followup
and a fracture risk of 0.5%. We found at last followup on
routine radiographs no evidence of osteolysis, and no
patient has been revised for squeaking or has reported
dissatisfaction with the clinical result because of noise.
Level of Evidence Level IV, therapeutic study. See the
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
The major advantages of alumina ceramic bearings for THA
include their hardness and scratch resistance, low coefficient
of friction, hydrophilic nature and superior lubrication, less
reactive particulate debris, and superior wear resistance [2, 5, 7].
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Early experiences dating back to the 1970s had failures
primarily related to aseptic loosening and ceramic fractures
[1, 6, 16]. In the mid-1990s a new generation of alumina
ceramic bearings was developed (Biolox Forte; Ceram Tec,
Plochingen, Germany) [7]. This new ceramic material is of
higher quality, has greater burst strength, and currently is
mated with implants that have excellent fixation records and
high taper tolerances [4, 7, 13, 16].
In October 1996, a US Investigational Device Exemption
(IDE), randomized controlled trial began comparing alu-
mina bearing couples with a chrome cobalt-on-conventional
polyethylene control system. At minimum 10-year followup
we reported, for the nontitanium-encased ceramic bearings,
substantially higher survivorship (96.6% versus 91%), zero
osteolysis, one ceramic insert fracture, 1% squeaking, and
three intraoperative insertion chips in three patients [4]
(Fig. 1).
In 1999 a second prospective IDE multicenter study of
ceramic hip bearings (194 patients, 209 hips) began using
the same implants with the exception of the ceramic insert
component, which was encased in a thin titanium sleeve
(Fig. 2). The titanium sleeve was added to in theory
improve overall survivorship by reducing ceramic fracture,
eliminating insertional chips, and by providing for a greater
ease of revision of insert. The primary objective of the
second study was to compare the incidence of bearing
fracture and insertion chipping with that of the predecessor
alumina ceramic bearing design. At a minimum followup
of 3 years (mean, 4.2 years; range, 3–5 years) we reported
no insertion ceramic chips or ceramic fractures [3].
The present study seeks to provide followup on that
earlier report. Our primary objective of this report was to
determine the overall survivorship of a cementless THA
system that used a titanium-encased ceramic-on-ceramic
bearing couple at 10-year followup. Our secondary objec-
tives were to evaluate for insertional chips, ceramic
fracture, osteolysis, and device squeaking.
Materials and Methods
Six surgeons at six institutions implanted 194 patients (209
hips) cementless hip implants with a titanium alloy stem
and alumina ceramic bearings (Trident; Stryker Orthopae-
dics; Mahwah, NJ, USA). Through a shrink-fit process, the
acetabular insert was encased in a thin titanium sleeve to
reduce the risk of insertional chips that occurred with the
previous design (Fig. 2). The titanium sleeve containing
the ceramic insert was then secured into a titanium
cementless cup through a reverse taper lock. The descrip-
tion of implants and patient inclusion criteria and
distribution of head sizes for the original study have pre-
viously been reported [3].
Clinical data and radiographs were collected preopera-
tively, early postoperatively (at 6–8 weeks), at 6 months, at
1 year, and at 1-year intervals thereafter through 5 years
and optional to 10 years. An FDA requirement for approval
of the device in 2003 was to continue a Post-Approval
Study (PAS) through 10 years. The objectives of the PAS
were to demonstrate continued safety through reporting
incidences of revision and complications through 10 years.
To assess the ongoing status of the hip for those patients,
a brief questionnaire was completed annually from 6 to
10 years postoperatively whether or not they returned
(Table 1). Optional clinical and radiographic followup at 7
and 10 years was obtained. In addition to the patients who
received the questionnaire, 77 patients had a clinical visit
with data collection and 60 had radiographs at 10-year
followup.
Of the 209 hips in the original study, five were lost to
death, four were revised, eight were lost to followup, and
three were lost due to patients declining to participate in
the PAS. Of the 190 who agreed to participate in the PAS,
seven patients died, two were revised and 35 were lost to
followup. These 35 patients were lost to followup between
5 and 10 years: 2 at 5 years, 6 at 7 years, 9 at 8 years, and
18 at 9 years. Of those who continued to participate, 152
Fig. 1 Ceramic insert developed a peripheral chip on seating and was
replaced at the time of surgery.
Fig. 2 The ceramic insert
shown is encased in a titanium
sleeve.
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patients (164 hips [78%]) had 9-year followup and 137
patients (146 hips [70%]) had followup through 10 years.
Of the 30% not followed at 10 years, 22% were lost to
followup and 8% died or were revised (Fig. 3).
Demographics for the 10-year patient population include
average age of 52 years and 65% male patients, which is
comparable to the original study cohort of 209 patients
(Table 2).
The survival rates, defined as absence of revision for any
reason and absence of revision for aseptic loosening or
bearing surface failure, were determined using the Kaplan-
Meier method [9]. The yearly hip followup questionnaire
consisted of three questions: (1) Are you satisfied with the
results of your THA? (2) Do you have any pain in your
hip? (3) Have you had any surgery on your hip in the past
year? If patients were not satisfied with their hip
arthroplasty, they were asked for the specific reason or
reasons.
The presence of osteolysis was determined by evaluat-
ing AP and lateral radiographs at each patient’s last visit;
CT scanning was not performed in this series.
The presence of squeaking was ascertained by ques-
tioning at each clinical visit, which was performed by a
member of the team who was not directly involved with
patient care. For those patients receiving the yearly hip
followup questionnaire, they were asked for specific rea-
sons for lack of satisfaction with the clinical result. They
were not asked to report on specific noise.
Categorical variables were summarized as count and
percentage, and the chi square test was used to test the
distribution difference between two groups. Continuous
numeric variables were summarized as mean and SD and
Wilcoxon test was used to compare population location
parameters between two groups. Survival functions for the
absence of revision for any reason and for aseptic loosen-
ing or bearing failure were graphed using the Kaplan-Meier
Trident IDE (N = 209)
Died = 5
Revised = 4
Lost to followup = 8
PAS (N = 193)   
3 declined
5 years
5 years
Died = 7 
Revised = 2 
Lost to followup =
35
10-year followup = 146)
Total died/revised 17/209 = 8%
Total lost to followup 46/209 = 22%
Fig. 3 Flow chart of number of hips
followed and reasons for exclusion
from onset to 10-year followup is
shown.
Table 1. Patient response in percent to questions on postcard followup for postapproval study from 6 to 10 years
Year (1) Percent yes satisfied (2) Percent no hip pain (3) Percent no surgery in the past year
6 N = 161 (97%) N = 141 (85%) No = 166 (100%)
7 N = 159 (98%) N = 136 (83%) No = 163 (100%)
8 N = 158 (98%) N = 138 (85%) No = 162 (100%)
9 N = 147 (99%) N = 126 (85%) No = 149 (100%)
10 N = 144 (99.%) N = 126 (87%) No = 145 (100%)
(1) Patient satisfaction (Are you satisfied with the THA?); (2) Do you have any hip pain? (3) Have you had surgery in the past year?
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method. All statistical tests were two-sided with a signifi-
cance level of 0.05. SAS/STAT software Version 9.1.3
(SAS Institute, Cary, NC, USA) was used for all data
analyses.
The demographic data were summarized and reported
by group with 10 years followup; comparisons were per-
formed to identify potential differences between those lost
to followup compared with either the original 209 hips or
10-year cohort. Statistical analysis demonstrated no dif-
ferences in patient sex, height, weight, or body mass index
between those lost to followup compared with either the
original 209 hips or 10-year cohort.
Results
For the entire population, the survivorship using revision for
any reason as the end point was 97% (Fig. 4A), and for
revision for aseptic loosening or bearing surface failure, it
was 99% (Fig. 4B). The major complications in this series
included six revisions (3.7%), four dislocations (2%), and
one fractured ceramic insert (0.5%) (Table 3). Revisions
have occurred postoperatively for the following reasons: two
(1%) revised at 2 years for recurrent instability; one (0.5%)
at 7 years for acetabular insert fracture; one (0.5%) revision
at 5 years for groin pain and tendonitis; one (0.5%) at 1 year
for acetabular component loosening; and one (0.5%) revi-
sion at 0.2 years for postoperative femoral fracture. This last
patient continued to be followed for 8 years.
No osteolysis has been found on routine radiographs at
the last followup visit.
Although two patients reported squeaking (1%), neither
was revised for noise and no patient reported dissatisfac-
tion with the clinical result because of squeaking.
Discussion
The primary objective of this followup report was to
determine the overall survivorship at 10 years of a
cementless THA system that used a titanium-encased
ceramic acetabular bearing with a ceramic-on-ceramic
bearing couple. Our secondary objectives were to evaluate
for insertional chips, ceramic fracture, osteolysis, and
device squeaking. The titanium sleeve was added to theo-
retically increase survivorship by reducing ceramic fracture
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Fig. 4A–B (A) The Kaplan-Meier survivorship end point aseptic
loosening and or bearing surface failure (99%). (B) The Kaplan-Meier
survivorship end point revision for any reason (97%).
Table 2. The demographics of original population and those
followed through 10 years are outlined
Demographics Total Trident: minimum
10 years
Number of cases 209 146
Number of patients 194 137
Male/female (%) 66%/34% 67%/33%
Mean age (years) 52 (± 10) 52 (± 10)
Mean weight (pounds) 190 (± 39) 190 (± 39)
Mean height (inches) 68 (± 4) 68 (± 4)
Mean body mass index
(kg/m2)
29 (± 5) 29 (± 6)
Length of followup (years) 9 (1–11) 10 (9–11)
Diagnosis 81% OA, 3% PTA,
11% AVN,
4% SCFE,
1% Fem Fx
84% OA, 2% PTA,
10% AVN,
3% SCFE,
1% Fem Fx
OA = osteoarthritis; PTA = posttraumatic arthritis; AVN = avas-
cular necrosis; SCFE = slipped capital femoral epiphysis; Fem Fx =
femoral fracture.
Table 3. Hip-related postoperative complications for total population
of patients
Complication Number (%)
Revision for instability (insert only) 2 (1)
Revision for insert fracture (insert only) 1 (0.5)
Revision acetabular loosening (shell, head, liner) 1 (0.5)
Revision periprosthetic femoral fracture (tem and head) 1 (0.5)
Revision (groin pain) (insert and head) 1 (0.5)
Dislocations 4 (2)
Squeaking noise (no revisions) 2 (1.0)
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and eliminating insertional chips. Although the sleeve did
eliminate the insertional chips seen with the previous
design, it was unknown what affect the sleeve would have
on overall survivorship.
Our study has limitations. First, 46 patients (22%) were
lost to followup over the 10-year period. As of the last
evaluation on these patients, the implants were still in
service and the patients were doing well; however, the
possibility exists that some could have been revised since
then or developed complications since the last visit. Sta-
tistical analysis demonstrated no differences in sex, height,
weight, or body mass index between those lost to followup
compared with either the original 209 hips or 10-year
cohort, suggesting that the 10-year patient cohort was
representative of the study population. However, it is not
possible to be certain that the population with complete
followup is entirely comparable to those who are lost to
followup. Although we have 70% followup of the original
cohort of patients, our followup percent is similar to those
studies recently reported with 10-year followup that range
from 70% to 93% (average 82% followup) [4, 10, 11, 18,
20–22]. The incidence of squeaking is probably underes-
timated in this report. Although patients were asked about
noise on return visits, the postcard survey did not specifi-
cally ask the question. We know that this results in an
underestimation of the prevalence of hip noise [8].
Although only two patients have reported squeaking, no
patient has reported dissatisfaction because of noise.
Another limitation is with the determination of osteolysis.
In our study, routine radiographs were used and not all
patients had radiographs through 10 years. We believe that
routine radiographs are sufficiently sensitive to detect
clinically important osteolytic lesions, but we agree with
literature that suggests CT scans offer more accuracy; we
consider the CT to be indicated when surgical intervention
is considered [12, 17]. Finally, the six surgeons in this
study were experienced with the implant systems used, and
the results may not be similar to a wider, less experienced
surgeon population.
When considering survivorship, osteolysis, ceramic
fracture, and squeaking, our results with a titanium-encased
ceramic liner agrees with our previous prospective study
and with six other current reports using nontitanium-
encased inserts, cementless implants with titanium alloy
stems, all with minimum 10-year followup [4, 10, 11, 18,
20–22]. Combining our current study results with those
seven reports, 1166 ceramic hip bearings are included and
found to have high survivorship, a 0.5% ceramic fracture
rate, rare osteolysis, and no known significant squeaking
issues (Table 4). The relatively young average age of our
patient of 52 years was similar to these reports (range,
24–58 years). Our survivorship using revision for any
reason of 97% and for aseptic loosening of 99% was the
same with their range, respectively, of 96% to 100% and
97% to 100%.
We experienced one insert fracture (0.5%), which is
similar to the three reported studies that had an insert
fracture (0.4%–1%) [4, 20, 22], One of the studies reported
two femoral head fracture (2%) [11], and three reported no
ceramic fractures.
Osteolysis when assessed with plain radiographs is
rarely seen with contemporary ceramic implants and our
experience agrees with the rare finding (0%–1%) in other
reports with minimum 10-year followup. Although our
incidence of squeaking may be underestimated because
patients were not specifically screened beyond 5 years, it
does agree with these reports (1%–3%) and also with a
meta-analysis covering 6137 patients (2.4%) [19] and is in
contrast to reports of 10% to 18% squeaking [8, 14, 15].
Although the presence of a titanium sleeve for the
acetabular insert has prevented insertional chips, it has not
resulted in any apparent improvement regarding survivor-
ship, osteolysis, ceramic fracture, or squeaking when
compared with those reports with 10 years followup that
Table 4. Published studies with minimum 10-year followup using Biolox Forte aluminum ceramic bearings for THA
Citations Followup
(years)
Number
of hips
Average
age (years)
Survival of revision
for any reason
Survival of
aseptic
loosening
Ceramic
fracture
Osteolysis Squeaking
Sugano et al. [20] 11–14 100 56 96% 97% 1% 1 insert 1% N/R
Solarino et al. [18] 13 68 50 97% 99% 0% 0% 0%
Yeung et al. [21] 10+ 244 58 98% 99% 0% 0% 0.3%
Kim et al. [10] 10–13 93 38 100% 100% 0% 0% 2%
Lee et al. [11] 10+ 88 41 97% 100% 2% 2 heads 0% 1%
D’Antonio et al. [4] 9–11 289 54 97% 100% 0.4% 1 insert 0% 1%
Yoon et al. [22] 10+ 75 24 99% 100% 1.3% 1 insert 0% 3%
Current study 10 146 52 97% 99% 0.5% 1 insert 0% 1%
N/R = not reported.
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did not use a titanium-encased insert. We determined no
complications that can be related to the addition of the
titanium sleeve.
The use of Biolox Forte titanium-encased inserts with
alumina ceramic bearings for THA with cementless
implants and a titanium alloy stem has high survivorship at
10 years of followup. Although ceramic fracture is rare, it
remains a risk for both the femoral head as well as the
socket insert. We believe that an alumina ceramic bearing
continues to provide an option for the young and more
active patient.
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